Neonatal respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in preterm infants. This condition stems primarily from an insufficiency in pulmonary surfactant, a ...

Wilmington, Delaware, United States, March 15, 2023 (GLOBE NEWSWIRE) -- The neonatal respiratory distress syndrome treatment market size was valued at US$ 780.1 Mn in 2022 and is expected to reach ...

Surfactant therapy has become a routine for neonatal respiratory care and already proved to reduce morbidity and mortality in neonatal respiratory distress syndrome. The surfactant replacement has ...

A gene change may explain why some newborn babies struggle for breath, and could lead to genetic biomarker-based tests to warn of the risk. Neonatal respiratory distress syndrome (RDS) is a breathing ...

Infant respiratory distress syndrome (RDS), sometimes referred to as neonatal RDS, is most common in babies born prematurely. When babies are born prematurely, their lungs may not be fully developed, ...

Neonatal Respiratory Distress Syndrome, Lung Ultrasound, Diagnosis, Application Progress Share and Cite: Zhang, C. and Wang, B. (2025) Advances in the Application of Lung Ultrasound in the Diagnosis ...

Global Neonatal Intensive Care Respiratory Devices Market OverviewThe global neonatal intensive care respiratory devices ...

Pregnant woman holding her stomach Maternal TSH levels >4 mIU/L are associated with increased risks for prematurity and neonatal respiratory distress syndrome. In pregnant women, maternal thyrotropin ...

The global neonatal intensive care respiratory devices market is expected to grow at a CAGR of ~6% during the forecast period. Rising incidence of preterm births and associated respiratory ...